Measurement of the cellular changes that occurred in the brains of the tauopathy mouse model with TPL2-KD along with reduced neurodegeneration and normalization of behavior reveal multiple potential beneficial aspects of preventing TPL2 kinase activity. This evidence concerns the gene MAP3K8 and tauopathy.